Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 796 results for "lymphocyte count"

Chronic Lymphocytic Leukaemia  ESMO Guidelines
Irish Medical Times

Ibrutinib as Initial Therapy for Patients with Chronic Lymphoc...

Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults in Western countries; it affects primarily older persons, with a median age at diagnosis of 72 years. 1,2 Chlorambucil has been a standard first-line therapy in CLL, ... New England Journal of Medicine, 2 months ago
Chronic Lymphocytic Leukaemia ESMO Guidelines Irish Medical Times, 2 months ago
Best Leukemia Abstracts from ASH 2015 Oncology Times, 3 weeks ago
Orthopedics Today

14-year-old male with history of ALL presents with perifollicular rash

A 14-year-old boy with a significant medical history of acute lymphocytic leukemia (ALL) was admitted awaiting blood count recovery after chemotherapy. You were consulted for evaluation of a papule on his gums. The patient has reported poor appetite ...
 MyInforms1 month ago Prothrombin G20210A Mutation in a 53-Year-Old Male Patient with Deep Vein Thrombosis  Lab Medicine1 month ago

Reversal of neutrophil-to-lymphocyte count ratio in early versus late death from septic shock

In the present study, we found that at the onset of septic shock, a low NLCR was associated with nonsurvival. This low NLCR was due to a higher lymphocyte count. When distinguishing time until death in the early-death (before day 5) and late-death ...
 Critical Care1 month ago

Lymphopenia as a predictor of sarcoidosis in patients with uveitis

Abstract Aims To investigate the hypothesis that lymphopenia is an independent predictor of sarcoidosis in new patients presenting with uveitis. Patients and methods Retrospective casecontrol study of 112 patients with sarcoidosis-associated ...
 British Journal of Ophthalmology1 month ago
Targeted Oncology

FDA Issues Venetoclax Priority Review as Second-Line Treatment in CLL

Stephan Stilgenbauer, MD Venetoclax has been granted priority review status by the FDA for use in adults with chronic lymphocytic leukemia (CLL) following at least 1 prior therapy. This patient population includes those with a 17p deletion ...
 Targeted Oncology3 weeks ago FDA grants priority review to venetoclax for CLL  Orthopedics Today3 weeks ago New Results from CLL11 Study Show Gazyva┬« Provided People with Previously Untreated Chronic Lymphocytic Leukemia a Treatment-free Period of Nearly Four Years  PressReleasePoint1 month ago Pivotal Phase II Study Showed Nearly 80 Percent Of People With Hard-To-Treat Type Of Chronic Lymphocytic Leukemia Responded To Investigational Medicine Venetoclax  Laboratory Network1 month ago
[x]  
Food Online

Flow Cytometer Performance Study For Lymphocyte Subset Analysis

A multi-center study was conducted to establish the performance of the AQUIOS CL Flow Cytometer with AQUIOS Tetra Panel reagents for lymphocyte subset analysis in patients suspected of immunodeficiency, post-transplant patients and apparently ...
 Bioresearch Online1 month ago

A microfluidic biochip for blood cell counts at the point-of-care

Teams of researchers from the University of Illinois at Urbana-Champaign (UIUC) have demonstrated a biosensor capable of counting the blood cells electrically using only a drop of blood. The blood cell count is among the most ubiquitous diagnostic ...
 MyInforms1 month ago Biochip Electrically Counts Blood Cells at Point-of-Care  Medical Design Technology1 month ago
[x]  

Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia (CLL) is the most prevalent leukemia among adults. Although chemoimmunotherapy prolongs the duration of remission and overall survival among most patients with CLL, 1,2 relapse virtually always occurs. This has prompted ...
 New England Journal of Medicine2 months ago
Medical News Today

Lymphoma: 67% complete response shown in Phase 1 BelCHOP study 7 Dec 2015

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations and a primary focus in Hematology and Oncology, and Onxeo S.A., an innovative company specializing in the development of orphan ...
 Medical News Today2 months ago Spectrum Pharmaceuticals And Onxeo Announce Complete Response In 67% Of Patients With Peripheral T-Cell Lymphoma In Combination Of Belinostat (Beleodaq┬«) And Standard CHOP  TheStreet.com2 months ago SPECTRUM PHARMACEUTICALS : and Onxeo Announce Complete Response in 67% of Patients with Peripheral T-Cell Lymphoma in Combination of Belinostat...  4 Traders2 months ago Phase 1 BelCHOP study shows belinostat and CHOP chemo regimen as first-line treatment for PTCL  News-Medical.Net2 months ago

Now, ART regardless of CD4 count

The article below represents a preview only and is not meant for reuse or republishing. Lucknow, Dec. 1 -- Pregnant women and TB patients living with HIV can now start antiretroviral therapy (ART) regardless of their CD4 count. Earlier, patients ...
 HT Syndication2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less